Home | Alzheimer's Drug Discovery Foundation
The ADDF's mission is to accelerate the discovery of drugs to prevent, treat, and cure Alzheimer's, other dementias, and cognitive aging by funding breakthrough research in …
Funding Opportunities | Alzheimer's Drug Discovery Foundation
The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias.
About Us | Alzheimer's Drug Discovery Foundation
The ADDF focuses on translating the knowledge we have gained about the causes of Alzheimer's disease – known as the “biology of aging” – into drugs to conquer it.
Staff | Alzheimer's Drug Discovery Foundation
Under her leadership, ADDF leverages venture philanthropy, global collaboration, and scientific rigor to catalyze breakthroughs and drive the next era of precision medicine for Alzheimer’s …
Diagnostics Accelerator | Alzheimer's Drug Discovery Foundation
Bill Gates and ADDF Co-Founder Leonard A. Lauder partnered to adopt a new approach that brings together philanthropic capital with a venture mindset to advance bold ideas for easier, …
Drug Development RFP | Alzheimer's Drug Discovery Foundation
Through the PACT program, the ADDF funds the early phases of clinical trials for novel drugs to treat Alzheimer's disease and related dementias.
Cognitive Vitality | Cognitive Vitality | Alzheimer's Drug Discovery ...
Oct 13, 2025 · Make smarter brain health choices with Cognitive Vitality. ADDF scientists evaluate the science and rate food, drink, drugs, vitamins, and supplements based on their potential …
Leadership | Alzheimer's Drug Discovery Foundation
Board members includes leaders from government, industry and the research community, who serve as ambassadors for the ADDF and provide strategic oversight and counsel.
Neuroimaging and CSF Biomarker Program | Alzheimer's Drug …
The ADDF funds the development and validation of biomarkers that will enhance the design and performance of clinical trials for Alzheimer's disease and related dementias.
Our Impact | Alzheimer's Drug Discovery Foundation
The ADDF supports one of the largest and most diverse clinical development portfolios for Alzheimer’s disease, with over 30 active clinical trials that span multiple drug targets.